160 related articles for article (PubMed ID: 37649434)
1. Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.
Jelinski J; Kowatsch MM; Lafrance MA; Berger A; Pedersen J; Azizi H; Li Y; Scholte F; Gomez A; Hollett N; Le T; Wade M; Fausther-Bovendo H; de La Vega MA; Babuadze G; Xiii A; Lamarre C; Racine T; Kang CY; Yao XJ; Alter G; Arts E; Fowke KR; Kobinger GP
Emerg Microbes Infect; 2023 Dec; 12(2):2251595. PubMed ID: 37649434
[TBL] [Abstract][Full Text] [Related]
2. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
[TBL] [Abstract][Full Text] [Related]
3. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
Egan MA; Chong SY; Megati S; Montefiori DC; Rose NF; Boyer JD; Sidhu MK; Quiroz J; Rosati M; Schadeck EB; Pavlakis GN; Weiner DB; Rose JK; Israel ZR; Udem SA; Eldridge JH
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):629-43. PubMed ID: 16060834
[TBL] [Abstract][Full Text] [Related]
4. V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.
Styles TM; Gangadhara S; Reddy PBJ; Sahoo A; Shiferaw A; Welbourn S; Kozlowski PA; Derdeyn CA; Velu V; Amara RR
Front Immunol; 2022; 13():914969. PubMed ID: 35935987
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
6. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
[TBL] [Abstract][Full Text] [Related]
7. Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.
Malherbe DC; Vang L; Mendy J; Barnette PT; Spencer DA; Reed J; Kareko BW; Sather DN; Pandey S; Wibmer CK; Robins H; Fuller DH; Park B; Lakhashe SK; Wilson JM; Axthelm MK; Ruprecht RM; Moore PL; Sacha JB; Hessell AJ; Alexander J; Haigwood NL
Front Immunol; 2020; 11():626464. PubMed ID: 33658998
[TBL] [Abstract][Full Text] [Related]
8. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
Clarke DK; Hendry RM; Singh V; Rose JK; Seligman SJ; Klug B; Kochhar S; Mac LM; Carbery B; Chen RT;
Vaccine; 2016 Dec; 34(51):6597-6609. PubMed ID: 27395563
[TBL] [Abstract][Full Text] [Related]
9. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
11. A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.
Sahoo A; Jones AT; Cheedarla N; Gangadhara S; Roy V; Styles TM; Shiferaw A; Walter KL; Williams LD; Shen X; Ozorowski G; Lee WH; Burton S; Yi L; Song X; Qin ZS; Derdeyn CA; Ward AB; Clements JD; Varadarajan R; Tomaras GD; Kozlowski PA; Alter G; Amara RR
Sci Immunol; 2022 Jul; 7(73):eabl4102. PubMed ID: 35867800
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
[TBL] [Abstract][Full Text] [Related]
13. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection.
Curtis AD; Saha PT; Dennis M; Berendam SJ; Ramasubramanian P; Cross KA; Alam SM; Ferrari G; Kozlowski PA; Fouda GG; Hudgens MG; Van Rompay KKA; Pollara J; Permar SR; De Paris K
mSphere; 2022 Feb; 7(1):e0083921. PubMed ID: 35196125
[TBL] [Abstract][Full Text] [Related]
15. Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
Binjawadagi B; Ma Y; Binjawadagi R; Brakel K; Harder O; Peeples M; Li J; Niewiesk S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408176
[TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
Mire CE; Geisbert JB; Marzi A; Agans KN; Feldmann H; Geisbert TW
PLoS Negl Trop Dis; 2013; 7(12):e2600. PubMed ID: 24367715
[TBL] [Abstract][Full Text] [Related]
17. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
[TBL] [Abstract][Full Text] [Related]
18. Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.
Bridge SH; Sharpe SA; Dennis MJ; Dowall SD; Getty B; Anson DS; Skinner MA; Stewart JP; Blanchard TJ
Virol J; 2011 Sep; 8():429. PubMed ID: 21899739
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail.
Nehete PN; Nehete BP; Hill L; Manuri PR; Baladandayuthapani V; Feng L; Simmons J; Sastry KJ
Virology; 2008 Jan; 370(1):130-41. PubMed ID: 17920095
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
